What is the classification of mitral stenosis with a Pulmonary Hypertension (PHT) of 137, mean mitral gradient of 4 mmHg, and Mitral Valve Area (MVA) of 1.6 cm^2?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Classification of Mitral Stenosis with PHT 137, Mean Gradient 4, and MVA 1.6 cm²

This patient has mild mitral stenosis with severe pulmonary hypertension based on the mitral valve area of 1.6 cm², mean gradient of 4 mmHg, and pulmonary hypertension of 137 mmHg.

Severity Classification Based on Guidelines

According to the American College of Cardiology guidelines, mitral stenosis severity is classified using three key parameters:

  • Mitral Valve Area (MVA):

    • Mild: >1.5 cm²
    • Moderate: 1.0-1.5 cm²
    • Severe: <1.0 cm² 1
  • Mean Transmitral Gradient:

    • Mild: <5 mmHg
    • Moderate: 5-10 mmHg
    • Severe: >10 mmHg 1, 2
  • Pulmonary Artery Systolic Pressure (PASP):

    • Mild: <30 mmHg
    • Moderate: 30-50 mmHg
    • Severe: >50 mmHg 1, 2

Analysis of Patient Parameters

  1. MVA of 1.6 cm²: This value falls into the mild mitral stenosis category (>1.5 cm²) 1, 2

  2. Mean gradient of 4 mmHg: This value falls into the mild mitral stenosis category (<5 mmHg) 1

  3. Pulmonary hypertension of 137 mmHg: This indicates extremely severe pulmonary hypertension, well above the threshold for severe (>50 mmHg) 1, 3

Clinical Implications

The discordance between the mild stenosis parameters (MVA and gradient) and the severe pulmonary hypertension is clinically significant:

  • Despite having mild stenosis by valve area and gradient criteria, the severe pulmonary hypertension suggests:

    • Longstanding disease
    • Possible pulmonary vascular remodeling
    • Potential right ventricular dysfunction 3
  • This combination may warrant consideration for intervention despite the mild stenosis parameters, as studies show that patients with mitral stenosis and pulmonary hypertension have significantly worse long-term outcomes 3

Potential Pitfalls in Assessment

  1. Discordant Parameters: When MVA and gradient suggest mild stenosis but pulmonary hypertension is severe, consider:

    • Other causes of pulmonary hypertension
    • Exercise-induced hemodynamic changes
    • Left atrial compliance issues 1
  2. Measurement Accuracy: Ensure accurate MVA measurement:

    • Direct planimetry with 3D echocardiography is preferred for accurate assessment 4
    • Pressure half-time method may be less reliable in certain conditions 4
  3. Clinical Correlation: The left atrial emptying index (AEI) can provide additional information about the functional significance of the stenosis 5

Management Implications

According to ACC/AHA guidelines, this patient with mild mitral stenosis but severe pulmonary hypertension may meet criteria for intervention consideration:

  • Class IIb indication for percutaneous balloon valvuloplasty in asymptomatic patients with moderate to severe mitral stenosis who have pulmonary hypertension (>50 mmHg at rest) 1

  • The presence of severe pulmonary hypertension (137 mmHg) significantly impacts long-term survival following mitral valve surgery, with a hazard ratio of 2.98 3

This case highlights the importance of considering all hemodynamic parameters rather than relying solely on MVA or gradient when determining the severity and management of mitral stenosis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mitral Stenosis Diagnosis and Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.